Risk of infection in patients with spondyloarthritis and ankylosing spondylitis receiving antitumor necrosis factor therapy: A meta-analysis of randomized controlled trials

Antitumor necrosis factor (TNF) agents have been widely used for the treatment of spondyloarthritis (SpA) and ankylosing spondylitis (AS). However, these agents may increase the risk of infection due to suppressing the immune response. The present meta-analysis was performed to systematically invest...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Zhigao, Xu, Peipei, Fan, Wei, Yang, Gui, Wang, June, Cheng, Qingyuan, Yu, Mingxia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639314/
https://www.ncbi.nlm.nih.gov/pubmed/29042938
http://dx.doi.org/10.3892/etm.2017.5003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5639314/
https://www.ncbi.nlm.nih.gov/pubmed/29042938
http://dx.doi.org/10.3892/etm.2017.5003

Ejemplares similares